Rejected at 12:56 a.m. Nov, 01, 2023 ] by Ahmed7
Author: sprinkleofnarnia
Related Note: 1481330892847
Rationale for change

Changed the question so people don't get confused with secondary polycythemia vera and think the answer is increased EPO.

Rejection reason

please resubmit with a source

Text Text
Extra
- Due to negative feedback suppressing renal EPO production

- Important distinguishing feature from secondary polycythemia
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid


Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
OME

Additional Resources
Other:

Helps differentiate polycythemia vera from secondary forms of polycythemia (e.g. chronic hypoxia, EPO-secreting tumors)


One by one
Empty field
Changed Tags
UWorld_MissedQs::IM
#AK_Step1_v12::#OME::Clinical::04_Organ_Systems::05_Hematology_Oncology::04_Proliferation::02_Myeloproliferation #AK_Step1_v12::^Other::^FA_Updates::FA2018 #AK_Step1_v12::#SketchyPath::10_Myeloid_&_Lymphoid::01_Myeloid_Disorders::03_Polycythemia #AK_Step1_v12::^Other::^EXPN::BGedit #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::10_Plasma_Cell_Dyscrasias_&_Myeloproliferative_Disease::03_Polycythemia_Vera_&_Essential_Thrombocythemia #AK_Step2_v12::#UWorld::COMLEX::28694 #AK_Step1_v12::#AMBOSS::CnaqvO #AK_Step2_v12::Original_decks::Dorian::im::emma #AK_Step2_v12::#AMBOSS::-t0DT3 #AK_Step2_v12::#Resources_by_rotation::IM::uw::heme/onc::heme/onc_zanki #AK_Step1_v12::#UWorld::Step::8559 #AK_Step1_v12::#OME::04_Organ_Systems::05_Hematology_Oncology::04_Proliferation::02_Myeloproliferation #AK_Step2_v12::#Resources_by_rotation::IM::ome::heme/onc::leukemia !AK_UpdateTags::Step1decks::Zanki-Step-Decks::Zanki-Hematology-&-Oncology::Pathoma-WBC #AK_Step2_v12::#UWorld::Step::2884 #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::03_White_Cells::02_Myeloproliferative_Disorders #AK_Step1_v12::#USMLERx::39393.6 #AK_Step1_v12::^Systems::HemeOnc::WBC #AK_Step2_v12::Original_decks::Dorian::im::uw::heme/onc #AK_Step2_v12::#Resources_by_rotation::IM::emma #AK_Step2_v12::#Resources_by_rotation::IM::uw::heme/onc::heme/onc_dorian #AK_Step2_v12::Original_decks::Dorian::im::ome::heme/onc::leukemia #AK_Step2_v12::#AMBOSS::ZF0Zg3 #AK_Step1_v12::#AMBOSS::4ma3fO #AK_Step2_v12::#OME::01_Medicine::05_Hematology_Oncology::05_Leukemia #AK_Step1_v12::#B&B::11_Hematology::03_White_Blood_Cells::07_Myeloproliferative_Disorders #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step1_v12::^Other::^HighYield::1-HighYield #AK_Step1_v12::#UWorld::COMLEX::25425 #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::31_Polycythemia::*Polycythemia_Vera #AK_Step2_v12::Original_decks::Zanki_Step_2::IM::HemeOnc #AK_Step1_v12::#Pathoma::06_WBC::04_Myeloproliferative #AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Hematology_&_Oncology::Pathoma_WBC #AK_Step2_v12::#AMBOSS::zt0rT3 #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::29_Myeloproliferative_neoplasms::01_Polycythemia_vera